In conclusion, our in vitro results demonstrate for the first time that CP plays a positive role in the efficiency of radiotherapy on GB cells and underlie the idea that radiotherapies may have to be adapted, when necessary, to the CP profile (or status) of tumor cells. This evidence concerns the gene CP and neoplasm.